TCR2 Therapeutics Inc. (TCRR)

TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $325.31)
- $325.31 P/E (TTM): 24.54X Cap: $175.17B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $752.62)
- $752.62 P/E (TTM): 17.73X Cap: $79.09B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $455.71)
- $455.71 P/E (TTM): 32.04X Cap: $115.62B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $169.38)
- $169.38 P/E (TTM): 22.53X Cap: $8.56B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,412.47)
- $1,412.47 P/E (TTM): 34.8X Cap: $28.85B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $5.71)
- $5.71 Cap: $458M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $11.47)
- $11.47 Cap: $60M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022